GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $162,397,000 | +14.9% | 2,384,677 | -46.1% | 0.01% | +25.0% |
| Q2 2022 | $141,332,000 | +18.1% | 4,423,544 | +28.0% | 0.01% | +33.3% |
| Q1 2022 | $119,716,000 | +29.0% | 3,456,012 | +9.0% | 0.01% | +50.0% |
| Q4 2021 | $92,819,000 | +17.2% | 3,171,135 | +2.0% | 0.00% | 0.0% |
| Q3 2021 | $79,185,000 | -1.7% | 3,107,727 | +35.1% | 0.00% | 0.0% |
| Q2 2021 | $80,575,000 | +6.8% | 2,300,827 | +24.3% | 0.00% | 0.0% |
| Q1 2021 | $75,445,000 | -23.5% | 1,851,408 | -18.6% | 0.00% | -33.3% |
| Q4 2020 | $98,561,000 | +9.0% | 2,275,709 | +38.7% | 0.01% | 0.0% |
| Q3 2020 | $90,438,000 | -8.7% | 1,640,159 | +4.5% | 0.01% | -14.3% |
| Q2 2020 | $99,064,000 | -11.4% | 1,569,205 | -28.3% | 0.01% | -30.0% |
| Q1 2020 | $111,753,000 | -34.8% | 2,187,383 | +1.4% | 0.01% | -16.7% |
| Q4 2019 | $171,526,000 | +49.1% | 2,157,828 | -9.0% | 0.01% | +33.3% |
| Q3 2019 | $115,064,000 | -0.1% | 2,371,467 | +8.3% | 0.01% | 0.0% |
| Q2 2019 | $115,216,000 | -9.2% | 2,190,413 | -8.7% | 0.01% | -10.0% |
| Q1 2019 | $126,927,000 | +41.3% | 2,398,015 | +9.6% | 0.01% | +25.0% |
| Q4 2018 | $89,821,000 | -8.8% | 2,188,096 | -15.6% | 0.01% | 0.0% |
| Q3 2018 | $98,541,000 | -9.9% | 2,593,164 | +7.1% | 0.01% | -11.1% |
| Q2 2018 | $109,394,000 | +10.7% | 2,420,163 | +18.3% | 0.01% | +12.5% |
| Q1 2018 | $98,840,000 | +37.9% | 2,046,395 | +12.3% | 0.01% | +33.3% |
| Q4 2017 | $71,691,000 | +15.3% | 1,821,809 | -9.1% | 0.01% | +20.0% |
| Q3 2017 | $62,202,000 | +6.4% | 2,003,420 | -6.3% | 0.01% | 0.0% |
| Q2 2017 | $58,479,000 | +135.9% | 2,138,323 | +217.9% | 0.01% | +150.0% |
| Q1 2017 | $24,788,000 | +493.9% | 672,728 | +132.0% | 0.00% | – |
| Q4 2016 | $4,174,000 | -36.7% | 289,984 | +1.4% | 0.00% | -100.0% |
| Q3 2016 | $6,593,000 | +121.9% | 285,960 | +59.7% | 0.00% | – |
| Q2 2016 | $2,971,000 | +99.3% | 179,026 | +90.7% | 0.00% | – |
| Q1 2016 | $1,491,000 | -47.6% | 93,872 | +6.5% | 0.00% | – |
| Q4 2015 | $2,846,000 | -10.2% | 88,108 | +17.1% | 0.00% | – |
| Q3 2015 | $3,170,000 | – | 75,233 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
| Grace Capital | 131,549 | $5,697,000 | 3.60% |
| Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
| Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
| Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
| Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
| ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
| Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
| Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
| Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |